Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|October 10, 2025
Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter studyRoman Kocian, Christhardt Kohler, Jaroslav Klat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 19, 2026
Effect of Weight Loss Amplitude Combined with Antiarrhythmic Drugs on Atrial Fibrillation Freedom, as compared to Catheter Ablation: A Sub-Analysis of the PRAGUE-25 TrialDalibor Heřman, Jana Veselá, Tomas Roubicek, et al.
Journal of the American College of Cardiology|July 2, 2025
Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE-25 TrialPavel Osmancik, Tomas Roubicek, Stepan Havranek, et al.
Journal of the American College of Cardiology|November 8, 2021
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 3, 2021
Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021Nathalie Nicolay, Francesco Innocenti, Julien Beauté, et al.
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Pageof 19